有必要更新新冠病毒“疑似病例”和“确诊病例”的诊断标准。
Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.
机构信息
Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Institute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, 475000, Henan, China.
出版信息
Mil Med Res. 2020 Apr 4;7(1):17. doi: 10.1186/s40779-020-00245-9.
Abstract
On 6 February 2020, our team had published a rapid advice guideline for diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infection, and this guideline provided our experience and make well reference for fighting against this pandemic worldwide. However, the coronavirus disease 2019 (COVID-19) is a new disease, our awareness and knowledge are gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. In this letter, we answered one comment on our guideline and provided the newest diagnostic criteria of "suspected case" and "confirmed case" according to the latest Diagnosis and Treatment Guidelines for COVID-19 (seventh version) that issued by the National Health Committee of the People's Republic of China.
摘要
2020 年 2 月 6 日，我们团队发布了 2019 年新型冠状病毒（2019-nCoV）感染的快速诊断和治疗指南，该指南为全球抗击这一流行疾病提供了我们的经验和参考。然而，新型冠状病毒肺炎（COVID-19）是一种新的疾病，我们的认识和知识正基于正在进行的研究结果和临床实践经验逐渐增加；因此，诊断和治疗策略也在不断更新。在这封信中，我们回应了对我们指南的一条评论，并根据中华人民共和国国家卫生健康委员会发布的《新型冠状病毒肺炎诊疗方案（试行第七版）》提供了最新的“疑似病例”和“确诊病例”的诊断标准。
相似文献
1
Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.有必要更新新冠病毒“疑似病例”和“确诊病例”的诊断标准。
Mil Med Res. 2020 Apr 4;7(1):17. doi: 10.1186/s40779-020-00245-9.
2
Primary stratification and identification of suspected Corona virus disease 2019 (COVID-19) from clinical perspective by a simple scoring proposal.从临床角度出发，通过一个简单的评分建议对疑似 2019 年冠状病毒病（COVID-19）进行初步分层和鉴别。
Mil Med Res. 2020 Apr 4;7(1):16. doi: 10.1186/s40779-020-00246-8.
3
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).新型冠状病毒（2019-nCoV）感染的肺炎快速诊治指南（标准版）。
Mil Med Res. 2020 Feb 6;7(1):4. doi: 10.1186/s40779-020-0233-6.
4
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
5
[What are the highlights of "Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team"].《新型冠状病毒感染疾病诊疗（适用于军队支援湖北医疗队）2019》的亮点有哪些？
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):315-320. doi: 10.3760/cma.j.cn112147-20200225-00183.
6
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version).《COVID-19 的化学预防、诊断、治疗和出院管理：基于证据的临床实践指南（更新版）》
Mil Med Res. 2020 Sep 4;7(1):41. doi: 10.1186/s40779-020-00270-8.
7
Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari "Aldo Moro" in Italy.用于 SARS-CoV-2、SARS-CoV、MERS-CoV 和 HCoV 大流行冠状病毒科家族成员的快速和敏感的多重检测的诊断程序：越南范周仁大学与意大利巴里大学“阿尔多·莫罗”之间的转化研究与合作。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7173-7191. doi: 10.26355/eurrev_202006_21713.
8
Impact of Shenfu injection on a composite of organ dysfunction development in critically ill patients with coronavirus disease 2019 (COVID-19): A structured summary of a study protocol for a randomized controlled trial.参附注射液对 2019 冠状病毒病（COVID-19）危重症患者器官功能障碍发展复合结局的影响：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Aug 24;21(1):738. doi: 10.1186/s13063-020-04677-5.
9
[Recommendations for normalizing the medical practices of burn treatment during the outbreak of coronavirus disease 2019].[关于2019冠状病毒病疫情期间规范烧伤治疗医疗行为的建议]
Zhonghua Shao Shang Za Zhi. 2020 Jun 20;36(6):465-469. doi: 10.3760/cma.j.cn501120-20200224-00083.
10
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
引用本文的文献
1
Biases in COVID-19 vaccine effectiveness studies using cohort design.使用队列设计的COVID-19疫苗有效性研究中的偏倚。
Front Med (Lausanne). 2024 Oct 30;11:1474045. doi: 10.3389/fmed.2024.1474045. eCollection 2024.
2
Coronavirus disease 2019 (COVID-19) excess mortality outcomes associated with pandemic effects study (COPES): A systematic review and meta-analysis.2019年冠状病毒病（COVID-19）与大流行影响相关的超额死亡率结局研究（COPES）：一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 Dec 16;9:999225. doi: 10.3389/fmed.2022.999225. eCollection 2022.
3
COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.2020 年 3 月至 2021 年 12 月英格兰儿童和青少年的 COVID-19 死亡病例：一项主动的全国前瞻性监测研究。
PLoS Med. 2022 Nov 8;19(11):e1004118. doi: 10.1371/journal.pmed.1004118. eCollection 2022 Nov.
4
Screening COVID-19 Suspected Cases and Determining the Associated Factors.筛查新型冠状病毒肺炎疑似病例及相关因素分析。
Front Public Health. 2022 Jul 12;10:901356. doi: 10.3389/fpubh.2022.901356. eCollection 2022.
5
COVID-19 and Selenium Deficiency: a Systematic Review.2019冠状病毒病与硒缺乏：一项系统综述
Biol Trace Elem Res. 2022 Sep;200(9):3945-3956. doi: 10.1007/s12011-021-02997-4. Epub 2021 Nov 5.
6
A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan.一项关于人工智能辅助流行病学对美国和日本新冠疫情进行预测的前瞻性评估。
NPJ Digit Med. 2021 Oct 8;4(1):146. doi: 10.1038/s41746-021-00511-7.
7
Fewer COVID-19-associated strokes and reduced severity during the second COVID-19 wave: The Madrid Stroke Network.第二波 COVID-19 期间 COVID-19 相关卒中减少且严重程度降低：马德里卒中网络。
Eur J Neurol. 2021 Dec;28(12):4078-4089. doi: 10.1111/ene.15112. Epub 2021 Sep 27.
8
How Should Athletes Coping With COVID-19: Focus on Severity and Psychological Support.运动员应如何应对新冠病毒：关注严重程度与心理支持。
Front Psychol. 2021 Jun 24;12:559125. doi: 10.3389/fpsyg.2021.559125. eCollection 2021.
9
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.伊维菌素粘膜粘附纳米混悬液鼻喷雾剂对减轻轻度 COVID-19 上呼吸道症状的临床、生化和分子评估。
Int J Nanomedicine. 2021 Jun 15;16:4063-4072. doi: 10.2147/IJN.S313093. eCollection 2021.
10
COVID-19 versus SARS: A comparative review.新型冠状病毒肺炎与严重急性呼吸综合征：比较综述。
J Infect Public Health. 2021 Jul;14(7):967-977. doi: 10.1016/j.jiph.2021.04.007. Epub 2021 Apr 24.
本文引用的文献
1
Primary stratification and identification of suspected Corona virus disease 2019 (COVID-19) from clinical perspective by a simple scoring proposal.从临床角度出发，通过一个简单的评分建议对疑似 2019 年冠状病毒病（COVID-19）进行初步分层和鉴别。
Mil Med Res. 2020 Apr 4;7(1):16. doi: 10.1186/s40779-020-00246-8.
2
A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).一种新发现的β冠状病毒、2019 年新型冠状病毒（2019-nCoV）蛋白同源建模指南。
J Med Virol. 2020 Sep;92(9):1542-1548. doi: 10.1002/jmv.25768. Epub 2020 Mar 29.
3
Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.在没有充分安全保障的情况下，不要急于部署新冠疫苗和药物。
Nature. 2020 Mar;579(7799):321. doi: 10.1038/d41586-020-00751-9.
4
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).新型冠状病毒感染（COVID-19）无症状感染率的估计。
Int J Infect Dis. 2020 May;94:154-155. doi: 10.1016/j.ijid.2020.03.020. Epub 2020 Mar 14.
5
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征：系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.
6
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
7
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.无症状携带者状态、急性呼吸道疾病和严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）引起的肺炎：事实与误区。
J Microbiol Immunol Infect. 2020 Jun;53(3):404-412. doi: 10.1016/j.jmii.2020.02.012. Epub 2020 Mar 4.
8
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
9
Coronavirus disease-2019: is fever an adequate screening for the returning travelers?2019冠状病毒病：发热是否足以筛查归国旅行者？
Trop Med Health. 2020 Mar 9;48:14. doi: 10.1186/s41182-020-00201-2. eCollection 2020.
10
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
Zotero 插件